Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Other Non-Current Liabilities: 2020-2025

Historic Other Non-Current Liabilities for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Sep 2025 value amounting to $38.0 million.

  • Maravai Lifesciences Holdings' Other Non-Current Liabilities fell 29.99% to $38.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.0 million, marking a year-over-year decrease of 29.99%. This contributed to the annual value of $52.5 million for FY2024, which is 11.81% down from last year.
  • Latest data reveals that Maravai Lifesciences Holdings reported Other Non-Current Liabilities of $38.0 million as of Q3 2025, which was down 0.57% from $38.2 million recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Other Non-Current Liabilities ranged from a high of $69.0 million in Q4 2022 and a low of $1.1 million during Q2 2021.
  • For the 3-year period, Maravai Lifesciences Holdings' Other Non-Current Liabilities averaged around $53.9 million, with its median value being $54.2 million (2024).
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' Other Non-Current Liabilities skyrocketed by 4,686.19% in 2022, and later dropped by 29.99% in 2025.
  • Maravai Lifesciences Holdings' Other Non-Current Liabilities (Quarterly) stood at $41.1 million in 2021, then spiked by 67.96% to $69.0 million in 2022, then dropped by 13.75% to $59.5 million in 2023, then decreased by 11.81% to $52.5 million in 2024, then fell by 29.99% to $38.0 million in 2025.
  • Its last three reported values are $38.0 million in Q3 2025, $38.2 million for Q2 2025, and $44.0 million during Q1 2025.